25,000 Shares in CEVA, Inc. (CEVA) Acquired by Weiss Multi Strategy Advisers LLC

Weiss Multi Strategy Advisers LLC bought a new position in CEVA, Inc. (NASDAQ:CEVA) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 25,000 shares of the semiconductor company’s stock, valued at approximately $888,000. Weiss Multi Strategy Advisers LLC owned 0.12% of CEVA at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. LS Investment Advisors LLC raised its position in shares of CEVA by 313.4% in the first quarter. LS Investment Advisors LLC now owns 2,935 shares of the semiconductor company’s stock valued at $104,000 after buying an additional 2,225 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of CEVA by 35.2% in the first quarter. Victory Capital Management Inc. now owns 3,249 shares of the semiconductor company’s stock valued at $115,000 after buying an additional 846 shares in the last quarter. Asset Management One Co. Ltd. acquired a new position in shares of CEVA during the fourth quarter valued at $123,000. Penserra Capital Management LLC raised its position in shares of CEVA by 75.0% in the first quarter. Penserra Capital Management LLC now owns 3,612 shares of the semiconductor company’s stock valued at $128,000 after buying an additional 1,548 shares in the last quarter. Finally, Mason Street Advisors LLC raised its position in shares of CEVA by 7.0% in the first quarter. Mason Street Advisors LLC now owns 4,965 shares of the semiconductor company’s stock valued at $176,000 after buying an additional 326 shares in the last quarter. Institutional investors own 88.53% of the company’s stock.

Institutional Ownership by Quarter for CEVA (NASDAQ:CEVA)

Shares of CEVA, Inc. (CEVA) traded up 0.75% during trading on Friday, reaching $47.05. 50,191 shares of the company traded hands. The firm has a market capitalization of $1.01 billion, a price-to-earnings ratio of 66.45 and a beta of 0.62. The company has a 50 day moving average price of $43.21 and a 200 day moving average price of $36.67. CEVA, Inc. has a 12-month low of $24.55 and a 12-month high of $48.67.

CEVA (NASDAQ:CEVA) last issued its quarterly earnings results on Thursday, May 4th. The semiconductor company reported $0.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.19 by $0.09. The firm had revenue of $21.30 million for the quarter, compared to the consensus estimate of $20.98 million. CEVA had a net margin of 19.90% and a return on equity of 7.99%. The company’s revenue for the quarter was up 29.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.17 EPS. On average, equities analysts predict that CEVA, Inc. will post $1.13 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by BBNS and is the property of of BBNS. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://baseballnewssource.com/markets/25000-shares-in-ceva-inc-ceva-acquired-by-weiss-multi-strategy-advisers-llc/1081650.html.

CEVA has been the topic of several analyst reports. Zacks Investment Research upgraded shares of CEVA from a “sell” rating to a “hold” rating in a report on Tuesday, April 4th. Canaccord Genuity increased their price objective on shares of CEVA from $41.00 to $42.00 and gave the company a “buy” rating in a report on Tuesday, April 25th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $42.00 price objective (up from $37.00) on shares of CEVA in a report on Friday, May 5th. Wunderlich restated a “buy” rating and issued a $40.00 price objective on shares of CEVA in a report on Monday, March 27th. Finally, Benchmark Co. increased their price objective on shares of CEVA from $42.00 to $50.00 and gave the company a “buy” rating in a report on Monday, June 5th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $41.14.

In other news, CFO Yaniv Arieli sold 59,764 shares of the business’s stock in a transaction that occurred on Friday, May 12th. The shares were sold at an average price of $42.91, for a total value of $2,564,473.24. Following the transaction, the chief financial officer now owns 52,249 shares in the company, valued at approximately $2,242,004.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Issachar Ohana sold 5,361 shares of the business’s stock in a transaction that occurred on Tuesday, May 9th. The stock was sold at an average price of $41.84, for a total transaction of $224,304.24. Following the completion of the transaction, the executive vice president now owns 35,822 shares in the company, valued at approximately $1,498,792.48. The disclosure for this sale can be found here. Insiders sold a total of 148,722 shares of company stock worth $6,346,768 in the last 90 days. Corporate insiders own 3.90% of the company’s stock.

CEVA Company Profile

CEVA, Inc (CEVA) is a licensor of signal processing intellectual property (IP). The Company partners with semiconductor companies and original equipment manufacturers (OEMs) to create connected devices for a range of end markets, including mobile, consumer, automotive, industrial and Internet of things (IoT).

Receive News & Ratings for CEVA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEVA Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.